|
|
Article: New Data Show Xenical(R) Significantly Reduces Cardiovascular Risk and More Than Doubles Weight Loss Achieved in Overweight and Obese People.
- Article from:
- PR Newswire Europe
- Article date:
- April 24, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BUDAPEST, Hungary, April 24 /PRNewswire/ -- The weight loss medication Xenical(R) (orlistat 120mg) significantly reduces weight and improves cardiovascular risk factors such as blood pressure, glycaemic control and lipid profile in overweight and obese people with type 2 diabetes and hypertension, according to a study analysis presented at the European Congress on Obesity (ECO), Budapest, Hungary.(1)
This analysis strengthens the wealth of data already established for Xenical that demonstrates that not only does it lead to significant weight loss, it also has remarkable benefits in reducing the risk of cardiovascular disease and diabetes, two of the world's ...